Related Experiment Video
Updated: Feb 2, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A
1Department of General Surgery, 305 Hospital of PLA, Beijing, China.
Abstract:
In this study, we aimed to explore the association between miR-99a-5p and CDC25A in breast cancer and the regulatory mechanisms of miR-99a-5p on breast cancer. The expressions of messenger RNA and microRNAs in breast cancer tissues and adjacent tissues were analyzed by the Cancer Genome Atlas microarray analysis. Quantitative real-time polymerase chain reaction was conducted to find out the expression levels of miR-99a-5p and CDC25A. The expression levels of proteins (CDC25A, ki67, cyclin D1, p21, BAX, BCL-2, BCL-XL, MMP2, and MMP9) were determined by Western blot analysis. The relationship between miR-99a-5p and CDC25A was predicted and verified by bioinformatics analysis and dual luciferase assay. After transfection, cell proliferation, invasion, and apoptosis of breast cancer tissues were, respectively, observed by cell counting kit-8 assay, transwell assay, and flow cytometry (FCM). Furthermore, the relationship among miR-99a-5p, CDC25A, and cell-cycle progression was determined by FCM assay. The nude mouse transplantation tumor experiment was performed to verify the influence of miR-99a-5p on breast cancer cell in vivo. The expression of miR-99a-5p in breast cancer tissues and cells was significantly downregulated, whereas CDC25A expression was upregulated. MiR-99a-5p targeted CDC25A and suppressed its expression in breast cancer cells. Overexpression of miR-99a-5p and decreased expression of CDC25A could suppress breast cancer cell proliferation and invasion and facilitate apoptosis. Cell-cycle progression was significantly activated by downregulated miR-99a-5p and upregulated CDC25A. Moreover, miR-99a-5p overexpression repressed the expressions of CDC25A, marker ki67, and Cyclin D1 proteins, whereas it upregulated the expression of p21 protein. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Insights
MicroRNA-99a-5p targets CDC25A, suppressing its expression in breast cancer. This microRNA (miRNA) inhibits cancer cell proliferation and invasion while promoting apoptosis, offering a potential therapeutic strategy.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Breast cancer is a significant global health concern with complex molecular underpinnings.
- Dysregulation of microRNAs (miRNAs) and their target genes plays a critical role in cancer development and progression.
- Understanding the specific roles of miRNAs like miR-99a-5p in breast cancer is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the association between miR-99a-5p and CDC25A in breast cancer.
- To elucidate the regulatory mechanisms of miR-99a-5p on breast cancer progression.
- To evaluate the therapeutic potential of modulating miR-99a-5p in breast cancer.
Main Methods:
- Analysis of gene and miRNA expression using The Cancer Genome Atlas (TCGA) microarray data.
- Quantitative real-time polymerase chain reaction (qRT-PCR) to measure miR-99a-5p and CDC25A levels.
- Western blot analysis for protein expression (CDC25A, ki67, cyclin D1, p21, BAX, BCL-2, BCL-XL, MMP2, MMP9).
- Bioinformatics analysis and dual luciferase assay to confirm the targeting relationship.
- In vitro assays (cell counting kit-8, Transwell, flow cytometry) to assess cell proliferation, invasion, and apoptosis.
- In vivo studies using a nude mouse xenograft model.
Main Results:
- miR-99a-5p was significantly downregulated, while CDC25A was upregulated in breast cancer tissues and cells.
- miR-99a-5p directly targets and suppresses CDC25A expression in breast cancer cells.
- Overexpression of miR-99a-5p inhibited cell proliferation and invasion, and promoted apoptosis.
- miR-99a-5p overexpression repressed CDC25A, ki67, and Cyclin D1, while upregulating p21.
- Downregulation of miR-99a-5p and upregulation of CDC25A activated cell-cycle progression.
Conclusions:
- miR-99a-5p acts as a tumor suppressor in breast cancer by targeting CDC25A.
- Modulating miR-99a-5p expression can inhibit breast cancer cell proliferation, invasion, and affect apoptosis.
- The miR-99a-5p/CDC25A axis is a critical regulator of breast cancer cell-cycle progression and represents a potential therapeutic target.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
What is the Cell Cycle?

